You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
McKinsey
Express Scripts
Baxter
Mallinckrodt

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202158


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 202158 describes RADIOGENIX SYSTEM, which is a drug marketed by Northstar Medical and is included in one NDA. Additional details are available on the RADIOGENIX SYSTEM profile page.

The generic ingredient in RADIOGENIX SYSTEM is technetium tc-99m sodium pertechnetate generator. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m sodium pertechnetate generator profile page.
Summary for 202158
Tradename:RADIOGENIX SYSTEM
Applicant:Northstar Medical
Ingredient:technetium tc-99m sodium pertechnetate generator
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INTRAVENOUS, INTRAVESICULAR, OPHTHALMICStrength30-1153mCi/GENERATOR
Approval Date:Feb 8, 2018TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Moodys
Harvard Business School
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.